Evangelista Charisma B, Harris Justin P, Trinh Toan M, Kohler Paul D, Mackie Ryan, Turovets Sergei, Aden James K, Capo-Aponte Jose E
From the Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center, Joint Base San Antonio-Lackland, Texas (Evangelista, Harris, Kohler, Capo-Aponte); Department of Ophthalmology, Brooke Army Medical Center, Joint Base San Antonio, Texas (Evangelista, Harris); United States Army Aeromedical Research Laboratory, Fort Novosel, Alabama (Trinh, Mackie, Turovets); Department of Graduate Medical Education, Brooke Army Medical Center, Joint Base San Antonio, Texas (Aden).
J Cataract Refract Surg. 2025 Feb 1;51(2):98-105. doi: 10.1097/j.jcrs.0000000000001565.
To assess the 6-month visual and refractive outcomes of keratorefractive lenticule extraction (KLEx) as compared with laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) in a military population at a Joint Warfighter Refractive Surgery Center.
Joint Warfighter Refractive Surgery Center (JWRSC), Lackland Air Force Base, San Antonio, Texas.
Retrospective study.
Patients who underwent KLEx, PRK, or LASIK between 2019 and 2022 were included. Anonymized data collected included demographics, preoperative and postoperative uncorrected and corrected visual acuity, and manifest refraction.
Of the 4466 treated eyes, 737 (16.5%) underwent the KLEx, 2801 (62.7%) underwent PRK, and 928 (20.8%) underwent LASIK treatment. Regarding efficacy, there was no statistically significant difference at postoperative month (POM) 6 between the percentage of eyes reaching an uncorrected distance visual acuity of 20/20 or better between the 3 procedures. At POM1 ( P < .001) and POM3 ( P < .001), there were a greater number of eyes in the KLEx group that achieved the same or 1 line better of distance visual acuity than the PRK group. The efficacy indices of KLEx, PRK, and LASIK at POM6 were 1.09, 1.10, and 0.97, respectively. The safety indices for KLEx, PRK, and LASIK at POM6 were 0.96, 1.01, and 0.81, respectively.
After the initial recovery period, KLEx demonstrates comparable outcomes in efficacy, safety, and accuracy as compared with LASIK and PRK.
在联合战士屈光手术中心评估角膜屈光透镜切除术(KLEx)与准分子原位角膜磨镶术(LASIK)和准分子激光角膜切削术(PRK)相比,在军事人群中的6个月视力和屈光结果。
联合战士屈光手术中心(JWRSC),得克萨斯州圣安东尼奥市拉克兰空军基地。
回顾性研究。
纳入2019年至2022年间接受KLEx、PRK或LASIK手术的患者。收集的匿名数据包括人口统计学信息、术前和术后未矫正及矫正视力,以及明显验光结果。
在4466只接受治疗的眼中,737只(16.5%)接受了KLEx手术,2801只(62.7%)接受了PRK手术,928只(20.8%)接受了LASIK手术。关于疗效,在术后第6个月(POM6),三种手术中达到未矫正远距离视力20/20或更好的眼的百分比之间无统计学显著差异。在术后第1个月(POM1,P <.001)和术后第3个月(POM3,P <.001),KLEx组中达到相同或比PRK组远距离视力好一行的眼的数量更多。KLEx、PRK和LASIK在POM6时的疗效指数分别为1.09、1.10和0.97。KLEx、PRK和LASIK在POM6时的安全指数分别为0.96、1.01和0.81。
在初始恢复期后,与LASIK和PRK相比,KLEx在疗效、安全性和准确性方面表现出相当的结果。